Qiagen announced an updated version of its clinical decision support platform, Qiagen Clinical Insight Interpret for NGS molecular profiling of hereditary and somatic diseases, has received the European Union, or EU, Technical Documentation Assessment and Quality Management System certificate under the European In Vitro Diagnostic Medical Device Regulation.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QGEN:
- QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support
- Qiagen announces FDA clearance for QIAstat-Dx Respiratory Panel Plus
- QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results
- Qiagen enters CRADA with FBI for QIAcuity digital PCR devices
- Qiagen Exceeds Q1 Expectations, Affirms 2024 Outlook